Greenberg Roy K, Clair Daniel, Srivastava Sunita, Bhandari Guru, Turc Adrian, Hampton Jennifer, Popa Matt, Green Richard, Ouriel Kenneth
Department of Vascualr Surgery, The Cleveland Clinic Foundation, Ohio 44195, USA.
J Vasc Surg. 2003 Nov;38(5):990-6. doi: 10.1016/s0741-5214(03)00896-6.
Treatment of abdominal aortic aneurysm is controversial in patients at high physiologic risk for open repair and high anatomic risk for endovascular repair. We compared outcome in patients at high risk because of anatomy (short or angulated neck), severe occlusive disease, or bilateral iliac aneurysms (group A) with outcome in patients at low risk (group B).
Patients at high anatomic risk who underwent treatment between October 1998 and March 2002 with the Zenith endovascular graft (group A) were compared with patients at low anatomic risk enrolled in a prospective multicenter trial (group B). Variables compared included overall mortality, need for secondary interventions, development of endoleak, and change in aneurysm sac diameter. The chi(2) test, Student t test, and proportions analysis were used to assess the data.
Data for 493 patients (group A, 141; group B, 352) were evaluated. Mean follow-up was 9 months (range, 1-24 months). Perioperative mortality was similar for groups A and B (0.7% vs 1%). Frequency of endoleak was higher in patients with high-risk anatomy (25% vs 11%), but not significantly so (P >.06). The rate of aneurysm shrinkage, even in the absence of endoleak, was slower in group A (P <.05).
In physiologically challenged patients at higher anatomic risk for endovascular aneurysm repair, initial mortality rate is similar to that in patients at lower risk. Short-term technical results are acceptable. Decreased long-term survival (largely unrelated to the procedure), slightly higher frequency of endoleak, and a lower rate of sac shrinkage may temper enthusiasm for endovascular repair in this subgroup. Risks of repairing aneurysms in this patient population must be viewed in the context of expected results of intervention or medical observation.
对于那些接受开放修复手术存在高生理风险、接受血管腔内修复手术存在高解剖风险的腹主动脉瘤患者,其治疗方案存在争议。我们比较了因解剖结构(颈部短或呈角状)、严重闭塞性疾病或双侧髂动脉瘤而处于高风险的患者(A组)与低风险患者(B组)的治疗结果。
将1998年10月至2002年3月间使用Zenith血管腔内移植物进行治疗的高解剖风险患者(A组)与参加前瞻性多中心试验的低解剖风险患者(B组)进行比较。比较的变量包括总死亡率、二次干预的需求、内漏的发生情况以及动脉瘤囊直径的变化。使用卡方检验、学生t检验和比例分析来评估数据。
对493例患者的数据(A组141例;B组352例)进行了评估。平均随访时间为9个月(范围1 - 24个月)。A组和B组的围手术期死亡率相似(0.7%对1%)。高风险解剖结构患者的内漏发生率更高(25%对11%),但差异无统计学意义(P>.06)。即使在没有内漏的情况下,A组动脉瘤缩小的速度也较慢(P<.05)。
对于血管腔内动脉瘤修复存在较高解剖风险且生理状况不佳的患者,其初始死亡率与低风险患者相似。短期技术结果是可以接受的。长期生存率降低(很大程度上与手术无关)、内漏发生率略高以及囊缩小率较低可能会降低对该亚组患者进行血管腔内修复的热情。在考虑对该患者群体进行动脉瘤修复时,必须结合干预或医学观察的预期结果来权衡风险。